The major SCFAs reduce lipogenesis and increase fatty acid oxidation, thermogenesis, and adipocyte browning in adipose tissue, muscle, and liver by increasing the expression of PGC1α, UCP1, and AMPK activation, which appear to have anti-obesity effects. The gene discussed is PPARGC1A; the disease is obesity due to melanocortin 4 receptor deficiency.